Purification of hepatocyte comitogenic factor in plasma membrane and its action site (s) in hepatocyte proliferation.

质膜中肝细胞有丝分裂因子的纯化及其在肝细胞增殖中的作用位点。

基本信息

  • 批准号:
    04454240
  • 负责人:
  • 金额:
    $ 4.42万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1993
  • 项目状态:
    已结题

项目摘要

Our previous observations show that rat plasma membrane has the ability to enhance induction of DNA synthesis by hepatocyte growth factors in cultured rat hepatocytes. The present study was attempted to purify this comitogenic factor from plasma membrane of rat hepatocytes and find its action sites. The following results have been so far obtained.1.PurificationThe comitogenic activity was extracted by collagenase digestion of the plasma membrane of rat hepatocytes partially purified according to the method of Hubbard et al., but the yield was too small to use for further purification by electrophoresis and column preparations. Although the yield was increased to 50% of the original activity by extraction with acetone, n-butanol or CHAPS,most of the activity was lost after column preparations with ion exchange resins. Antiserum against such extracts made using rabbits inhibited DNA synthesis by cultured rat hepatocytes, but immunoblot analysis revealed a lot of bands in the antiserum. To obtain hybridoma for a monoclonal antibody against the factor has not yet been successful.2.Action site(s)The plasma membrane increased concentrations of putrescine, an essential polyamine for hepatocyte proliferation, in cultured rat hapatocytes, while it abolished completely the decrease in DNA synthesis by the hepatocytes induced by ddition of TGF beta. When rats underwent 70% hepatectomy, the comitogenic activity in the liver was gradually decreased after 6 hr and disappeared at 24 hr, but recovered to normal levels at 31 hr. The comitogenic factor might act at the G1-phase of the cell cycle in association with putrescine production, and be inactivated or consumed during exerting its action.
我们之前的观察表明,大鼠质膜具有增强培养大鼠肝细胞中肝细胞生长因子诱导DNA合成的能力。本研究试图从大鼠肝细胞质膜中纯化这种致精因子并找到其作用位点。目前已获得如下结果: 1.纯化 按照Hubbard等人的方法,对部分纯化的大鼠肝细胞质膜进行胶原酶消化,提取促有丝分裂活性,但得率太小,无法用于进一步纯化。电泳和柱制备。虽然用丙酮、正丁醇或CHAPS萃取可以将收率提高到原始活性的50%,但在用离子交换树脂制备柱后大部分活性丧失。用兔子制备的针对此类提取物的抗血清抑制了培养的大鼠肝细胞的DNA合成,但免疫印迹分析显示抗血清中存在许多条带。获得针对该因子的单克隆抗体的杂交瘤尚未成功。2.作用位点在培养的大鼠肝细胞中,质膜增加了腐胺的浓度,腐胺是肝细胞增殖所必需的多胺,同时完全消除了腐胺浓度的降低。添加 TGF β 诱导肝细胞进行 DNA 合成。当大鼠接受70%肝切除术时,肝脏中的促致精活性在6小时后逐渐降低,并在24小时时消失,但在31小时时恢复到正常水平。促有丝分裂因子可能在细胞周期的 G1 期起作用,与腐胺的产生有关,并在发挥其作用期间被失活或消耗。

项目成果

期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nagoshi S: "Stimulation of Putrescine Produaction by Epiderinal Growth Factor in Rat hiver after Partial Hepntectomy" Hepatology. 14. 901-905 (1991)
Nagoshi S:“部分肝切除术后大鼠冬眠中表皮生长因子对腐胺的刺激”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
富谷智明ら: "Serum Hepatocyte Growth Factor Levels in Hepatectomized and Non-hepatectomized Surgical Patients." Gastroenterology. 103. 1621-1624 (1992)
Tomoaki Tomiya 等人:“肝切除和非肝切除手术患者的血清肝细胞生长因子水平。胃肠病学”103。1621-1624 (1992)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
藤原 研司: "肝再生" Mebio. 11. 27-31 (199)
藤原健二:“肝脏再生”Mebio 11. 27-31 (199)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masaki N: "Hipatocyte Membrane Stabilizationly Prostag Candin E_1 and E_2 in Favorable Effects on Rat hiver Ingury" Gastroenterology. 102. 572-576 (1992)
Masaki N:“肝细胞膜稳定前列腺癌 Candin E_1 和 E_2 对大鼠 hiver Ingury 的有利影响”胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
藤原 研司: "Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats." Hepatology. 18. 1443-1449 (1993)
Kenji Fujiwara:“外源性人肝细胞生长因子对正常和部分肝切除大鼠的肝脏生长的刺激”,18. 1443-1449 (1993)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJIWARA Kenji其他文献

FUJIWARA Kenji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJIWARA Kenji', 18)}}的其他基金

Suppression of Pancreatic cancer neural invasion by regulation of Axon guidance molecule
调控Axon引导分子抑制胰腺癌神经侵袭
  • 批准号:
    20K22817
  • 财政年份:
    2020
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
NQR Study of Superconducting Mechanism mediated by Valence Fluctuations
价态涨落介导的超导机制的NQR研究
  • 批准号:
    21540338
  • 财政年份:
    2009
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetic Polymorphisms in Promoter Regions of Osteopontin Gene as Host Factors to Determine Th1 Immune Reactions against Hepatitis Virus.
骨桥蛋白基因启动子区的遗传多态性作为宿主因素确定针对肝炎病毒的 Th1 免疫反应。
  • 批准号:
    14370191
  • 财政年份:
    2002
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on Strategies for Non-Heart Beating Liver
肝脏无心跳治疗策略研究
  • 批准号:
    11470137
  • 财政年份:
    1999
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New devices in anticoagulant therapy for massive hepatic necrosis through sinusoidal fibrin deposition
通过肝窦纤维蛋白沉积抗凝治疗大面积肝坏死的新装置
  • 批准号:
    06454258
  • 财政年份:
    1994
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Factors Associated with Insufficient Liver Regeneration in Fulminant Hepatic Failure
暴发性肝衰竭中肝脏再生不足的相关因素
  • 批准号:
    01480223
  • 财政年份:
    1989
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
ROLE OF SUPEROXIDE FROM MACROPHAGES IN HEPATIC FIBROSIS
巨噬细胞超氧化物在肝纤维化中的作用
  • 批准号:
    60480207
  • 财政年份:
    1985
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

新型骨髓间充质干细胞NG2+/BmMSCs亚群向胆管细胞定向分化功能鉴定及其分子调控机制研究
  • 批准号:
    81873586
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
载VEGF纳米粒子联合肝细胞移植对肝血管新生影响及机制研究
  • 批准号:
    81070360
  • 批准年份:
    2010
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目
转HGF基因骨髓间充质干细胞对小移植肝保护机制的研究
  • 批准号:
    30872390
  • 批准年份:
    2008
  • 资助金额:
    8.0 万元
  • 项目类别:
    面上项目
载肝细胞生长因子纳米粒子在肝细胞移植中的应用
  • 批准号:
    30772130
  • 批准年份:
    2007
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目
细胞生长因子对肝再生协同调控的实验研究
  • 批准号:
    39470677
  • 批准年份:
    1994
  • 资助金额:
    7.0 万元
  • 项目类别:
    面上项目

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
Diverging roles of EGFR and MET in acetaminophen-induced acute liver injury
EGFR 和 MET 在对乙酰氨基酚诱导的急性肝损伤中的不同作用
  • 批准号:
    10633557
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
The Role of Macrophages in Hepatobiliary Development
巨噬细胞在肝胆发育中的作用
  • 批准号:
    10680846
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
The role of liver progenitor cells in liver regeneration
肝祖细胞在肝再生中的作用
  • 批准号:
    10607301
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
Nucleus-to-cytoplasm trafficking of chromatin fragments in senescence and aging
衰老和衰老过程中染色质片段从核到细胞质的运输
  • 批准号:
    10722474
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了